No classical molecular drug target

The designation "No classical molecular drug target" is applied to therapeutic agents that do not achieve their effects by binding to specific regulatory proteins such as receptors, enzymes, or transporters (Rang & Dale's Pharmacology, 9th Ed, 2019). Instead, these drugs operate through broad physicochemical mechanisms, such as the chemical neutralization of stomach acid by antacids or the creation of osmotic gradients by agents like mannitol (Goodman & Gilman's, 13th Ed, 2017). Other examples include surfactants like simethicone, which alter the surface tension of gas bubbles, and adsorbents like activated charcoal that physically bind toxins in the gastrointestinal tract (StatPearls, 2023). While these agents lack the high specificity of modern targeted therapies, they remain clinically vital for managing conditions where a physical or chemical change in the physiological environment is required. Understanding this category is crucial for biotech analysts to differentiate between drugs requiring molecular docking studies and those whose efficacy is governed by basic chemical laws.

Other names

Non-specific drug actionPhysicochemical mechanismNon-receptor mediated actionNon-specific mechanism

Drugs in this category function through non-specific chemical or physical processes, such as acid-base neutralization, osmotic fluid shifts, or physical adsorption, rather than through stereospecific binding to protein targets (Rang & Dale's Pharmacology, 9th Ed, 2019).